Roivant Sciences (NasdaqGS:ROIV) Q2 2026 Earnings Call November 10, 2025 08:00 AM ET Company ParticipantsCorinne Johnson - VP of Equity ResearchMatt Gline - CEOStephanie Lee - Head of Investor RelationsBrandon Frith - AssociateConference Call ParticipantsNone - AnalystNone - AnalystThomas Smith - Senior Research AnalystRon Werber - Managing Director and Senior Biotechnology AnalystBrian Cheng - Biotech AnalystDennis Ding - Biotech Equity Research AnalystDavid Risinger - Senior Managing Director and Senior R ...

Immunovant (NasdaqGS:IMVT) Q2 2026 Earnings Call November 10, 2025 08:00 AM ET Company ParticipantsStephanie Lee - COOMatt Gline - CEOConference Call ParticipantsYaron Werber - AnalystCorinne Jenkins - AnalystBrian Cheng - AnalystDouglas Tsao - AnalystPrakhar Agrawal - AnalystBrandon Frith - AnalystNone - AnalystDominic Lorenzi - AnalystThomas Smith - AnalystDave Risinger - AnalystDennis Ding - AnalystSamantha Semenkow - AnalystNone - AnalystOperatorGood day, and thank you for standing by. Welcome to Immuno ...

Immunovant (NasdaqGS:IMVT) Q2 2026 Earnings Call November 10, 2025 08:00 AM ET Speaker1Good day, and thank you for standing by. Welcome to Immunovant's second quarter 2025 earnings call. At this time, all participants are in the listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. Please note that today's con ...